Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001408443-18-000001
Filing Date
2018-10-26
Accepted
2018-10-26 16:54:04
Documents
1
Effectiveness Date
2018-10-26
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13984
  Complete submission text file 0001408443-18-000001.txt   15054
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL a8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL a8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8
Type: D | Act: 33 | File No.: 021-324502 | Film No.: 181142154